In a recent report, Albert Bourla, the chairman and chief executive of the global pharmaceutical giant Pfizer Inc accepted the prestigious Genesis award for his work leading to the very first vaccine for COVID-19 to be authorized for distribution in the U.S. and Europe. [2]
This prize is a million dollar U.S. award granted each year to an individual for “professional achievements, contributions to humanity and commitment to Jewish values.” [3]
Cited among reasons expressed for this season’s choice was Pfizer’s decision to turn down funding from the U.S. government early on “ a decision that helped the company reduce bureaucracy and expedite development of the vaccine.” (Although this courtesy does not extend to all the booster shots many are being coerced into taking as we move forward.) [4][5]…
